Credit score: Pietro Jeng from Pexels
A category of diabetes medicines, which embrace the best-selling drug Ozempic, are related to a decreased threat of sure obesity-related cancers, in line with a research launched Friday.
Revealed within the journal JAMA, the research in contrast sufferers with Sort 2 diabetes who had been handled with insulin versus sufferers who got a category of drug generally known as GLP-1 agonists, like Ozempic, between 2005 and 2018.
The researchers discovered that the sufferers who acquired GLP-1 agonists had a considerably decrease threat of growing 10 out of 13 cancers studied, together with kidney, pancreatic, esophageal, ovarian, liver and colorectal most cancers.
Among the many cancers which noticed no important change in threat had been thyroid most cancers and breast most cancers in postmenopausal girls.
“Weight problems is well-known to be related to not less than 13 most cancers varieties,” research creator Rong Xu stated in an electronic mail to AFP.
“Our research offers proof that GLP-1RAs maintain promise in breaking the hyperlink between weight problems and most cancers,” Xu stated.
Among the many medication studied had been semaglutide—commercially offered as Ozempic—in addition to liraglutide and others. Ozempic was accredited in america in 2017.
GLP-1 agonists have been round for about 20 years, however a brand new era of those medication, amongst them Ozempic, has been popularized for his or her extra important weight reduction results.
Xu advised that the protecting advantages demonstrated within the research could encourage medical doctors to prescribe GLP-1 therapies for diabetes sufferers as an alternative of different medicines like insulin.
Extra info:
Lindsey Wang et al, Glucagon-Like Peptide 1 Receptor Agonists and 13 Weight problems-Related Cancers in Sufferers With Sort 2 Diabetes, JAMA Community Open (2024). DOI: 10.1001/jamanetworkopen.2024.21305
© 2024 AFP
Quotation:
Diabetes medication like Ozempic decrease most cancers dangers: Examine (2024, July 6)
retrieved 6 July 2024
from https://medicalxpress.com/information/2024-07-diabetes-drugs-ozempic-cancer.html
This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.